NeuroRx and Relief Therapeutics submit Emergency Use Authorization for COVID-19 in USA
NeuroRx and Relief Therapeutics submit Emergency Use Authorization for COVID-19 in USA
About this item
Full title
NeuroRx and Relief Therapeutics submit Emergency Use Authorization for COVID-19 in USA
Publisher
IMSworld Publications Ltd
Journal title
R and D focus drug news, 2020-09
Language
English
Formats
Publication information
Publisher
IMSworld Publications Ltd
Subjects
More information
Alternative Titles
Full title
NeuroRx and Relief Therapeutics submit Emergency Use Authorization for COVID-19 in USA
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_incontextgauss__A636433035
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss__A636433035
Other Identifiers
ISSN
1350-1135
E-ISSN
1350-1135
How to access this item
Log in as a Library member